Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gastric Cancer Precursor Lesions (GCPL) Study

NCT03188406 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03188406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gastric Cancer Precursor Lesions (GCPL) Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
May 2, 2017
Completion date
April 28, 2020
Enrollment
1,300 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, intestinal metaplasia